Cryo-Save director stocks up on shares

Werner Spinner, a non-executive director at the stem cell bank group Cryo-Save, has topped up his stake in the company, taking about £20,000 worth of shares.

Spinner, who served for 30 years with the German drug giant Bayer, took 25,000 shares at 77.2p a time.

He now has 284,868 shares or about 0.6% of Cryo-Save.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Cryo-Save, which has its headquarters in the Netherlands and stores more than 100,000 adult stem cells in storage facilities in Belgium, Germany and Dubai, last month reported a fall in full-year profits due to higher operating expenses, but said it was well positioned to capitalise on its international position.

Revenue was up 67% to €29.5m in the year ended 31 December, while pre-tax profit fell to €2.86m compared with €4.51m last time as operating expenses rose to €17.9m from €7.13m previously.

Top Director Buys

Value: £49,980

Value: £19,740

Value: £19,300

Value: $12,000

Value: £10,183

Top Director Sells

Value: £2,400,000

Value: £2,400,000

Value: £960,000

Value: £321,922

Value: £119,138

Value: £53,472

Value: £41,736

Value: £38,244

Value: £35,123

Value: £12,000